SMTL ID : 6pu7.2 (1 other biounit)

Human IDO1 in complex with compound 17 (N-{2-[(4-{N-[(7S)-4-fluorobicyclo[4.2.0]octa-1,3,5-trien-7-yl]-N'-hydroxycarbamimidoyl}-1,2,5-oxadiazol-3-yl)sulfanyl]ethyl}acetamide)

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.43 Å

Oligo State

monomer

Ligands

1 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)

HEM.1: 23 residues within 4Å: Chain A: Y.117, F.154, S.158, V.161, F.205, F.217, S.254, A.255, G.256, F.261, F.282, L.283, R.334, H.337, I.340, V.341, Y.344, I.345, L.375, F.378, L.379, V.382 Ligands: OY4.2 19 PLIP interactions: 19 interactions with chain A, Hydrophobic interactions: A:F.154, A:V.161, A:F.205, A:F.205, A:F.217, A:F.261, A:F.261, A:F.282, A:L.283, A:I.340, A:V.341, A:Y.344, A:Y.344, A:F.378, A:L.379 Hydrogen bonds: A:S.254 Water bridges: A:R.334 Salt bridges: A:R.334 Metal complexes: A:H.337

1 x OY4: N-{2-[(4-{N-[(7S)-4-fluorobicyclo[4.2.0]octa-1,3,5-trien-7-yl]-N'-hydroxycarbamimidoyl}-1,2,5-oxadiazol-3-yl)sulfanyl]ethyl}acetamide(Non-covalent)

OY4.2: 14 residues within 4Å: Chain A: Y.117, C.120, V.121, F.154, S.158, F.217, R.222, L.225, S.226, G.253, S.254, A.255, G.256 Ligands: HEM.1 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:Y.117, A:V.121, A:F.154, A:L.225, A:A.255 Hydrogen bonds: A:G.253, A:A.255, A:G.256

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhang, H. et al., Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy. Acs Med.Chem.Lett. (2019)

Release Date

2019-12-04

Peptides

Indoleamine 2,3-dioxygenase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Indoleamine 2,3-dioxygenase 1

Related Entries With Identical Sequence